Optimizing Treatment in Patients with ROS1 Rearranged NSCLC cover art

Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

Written by: Annenberg Center for Health Sciences
Listen for free

About this listen

 Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.Annenberg Center for Health Sciences Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Introduction and Key Takeaways

    Introduction and Key Takeaways
    Oct 7 2024

    This full educational program can be accessed at no cost here: https://annenberg.net/courses/landingPage.php?courseID=61030
    Show More Show Less
    15 mins
No reviews yet